Skip to main content
Caplight Logo









Alercell, Inc.

Alercell, Inc.

Private
Bozeman, MontanaHealthcare & Life Scienceshttps://www.alercell.com/

Last Round

Series A

Mar 23, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Alercell, Inc. is a precision oncology biotechnology company that develops AI-powered epigenetic diagnostic platforms for the early detection of leukemia and other cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticsepigenetic testingprecision oncologylaboratory developed testsLDTcancer detectionleukemia screeningliquid biopsyAI diagnosticsmedical AIDNA methylationtheranosticsclinical laboratoryCLIA certifiedearly cancer detectionbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alercell, Inc. Comparables

Compare Alercell, Inc. with similar companies based on industry and business-model similarity.

Alercell, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
METHYS Dx
83%
Singlera Genomics Inc.
80%
Adela
78%

Alercell, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 23, 2026

Key People

Founding team and executive leadership

Alexandre Scheer

Chief Medical Officer & co-Founder

Founding Team

Frederic Scheer

Chief Executive Officer, Chief Scientific Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 23, 2026

    Completed a Series A funding round.

  • Dec 15, 2024

    Monthly visitors grew 100% MoM.

Alercell, Inc. Filings

Explore SEC and related filing metadata, where available.

Alercell, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alercell, Inc.'s valuation, stock price, and market status.

Is Alercell, Inc. a public or private company?

Alercell, Inc. is a private company.

What is the current stock price of Alercell, Inc.?

Alercell, Inc. is a private company with no public stock price. Caplight tracks Alercell, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Alercell, Inc. worth (valuation)?

Valuation information for Alercell, Inc. is not publicly available.

Can I buy Alercell, Inc. stock?

Alercell, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alercell, Inc.'s last funding round?

Alercell, Inc.'s most recent funding round was Series A on March 23, 2026.

Who are the main investors in Alercell, Inc.?

Investor information for Alercell, Inc. is not publicly disclosed.

Will Alercell, Inc. IPO soon?

No public IPO plans have been announced for Alercell, Inc..

How can I track Alercell, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alercell, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBozeman, Montana
Employee Range5
Year Founded2020
Last FundingMar 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?